Top Markets
#1 Purr Purr +62.52%
#2 Smilek to the Bank Smilek to the Bank +50.56%
#3 Pons Pons +26.23%
#4 Kinetiq Kinetiq +23.23%
#5 ApeX ApeX +22.46%
#6 Not in Employment, Education, or Training Not in Employment, Education, or Training +20.08%
#7 Zora Zora +19.59%
#8 OriginTrail OriginTrail +17.77%
#9 Non-Playable Coin Non-Playable Coin +17.52%
#10 Morpho Morpho +16.59%
Coin of the day
Purr Purr
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
SYN-TECH Chem. & Pharm. Co., Ltd. SYN-TECH Chem. & Pharm. Co., Ltd.

SYN-TECH Chem. & Pharm. Co., Ltd.

1777
Classifica tra le azioni #21548
SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical... SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulcerative, antihypertensive, a-blocker, vasodilator, bronchodilator, anxiolytic, tranquilizer, local anesthetic, decongestant, antispasmodic, neuroprotective, antimigraine, pharmaceutic aid/lubricant, antiglaucoma agent, hyponatremia, antidepressant, sedative, and analgesic, as well as treatment for hyperparathyroidism and urinary frequency, benign prostatic hypertrophy, and Herpes virus helicase-primase inhibitor. SYN-TECH Chem. & Pharm. Co., Ltd. was founded in 1982 and is based in Tainan City, Taiwan.
Prezzo delle azioni
$2.36
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$105.07M
Variazione (1 giorno)
0.14%
Variazione (1 anno)
-5.05%
Paese
TW
Scambia SYN-TECH Chem. & Pharm. Co., Ltd. (1777)

Categoria

Healthcare
Ricavi di SYN-TECH Chem. & Pharm. Co., Ltd. (1777)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di SYN-TECH Chem. & Pharm. Co., Ltd., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per SYN-TECH Chem. & Pharm. Co., Ltd. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT